Sanofi Stock SAN, quote Euronext Paris

Previous close	87.31
Open	87.57
Bid	0.00 x 0
Ask	0.00 x 0
Day's range	86.20 - 87.80
52 week range	80.60 - 105.18
Volume	896,675
Average volume	1,419,566

Market Cap	109.12B
Beta (5 year Monthly)	0.44
PER	20.19
EPS	4.30
Earnings date	Apr 25, 2024
Forward dividend & yield	3.56 (4.08%)
Ex-Dividend date	May 30, 2023
1 year target	102.50

Sanofi stock reports 2025 sales of 39 175 000 000.
Its closing price is 87.31 and analysts have a target price of 102.50. In the last 52 weeks, its price has fluctuated between 80.60 and 105.18.
Sanofi has a market capitalization of 119250000000, a PER of 20.19 and earnings per share of 4.30.

Finances Sanofi

Earnings & revenue

Total revenue

Net Income

Gross profit

Free Cash Flow

Revenue estimate number of analysts : 24

Valuation

52 week range

80.60

87.31

105.18

1 year target

87.31

<- 17% ->

102.50

PER
20.19

PEG
2.63

P/FCF
14

Price to Book
1.64

Book value
58.03

Return on Equity
N/A

Return on Assets
N/A

Financials

All figures on Sanofi for the last 5 years.

Statistics

Valuation

Marketcap (intraday)	119.25B
Enterprise value	132.28B
Trailing P/E	13.17
Forward P/E	11.82
PEG Ratio (5 yr expected)	2.63
Price to sales (ttm)	2.61
Price to Book (MRQ) (mrq)	1.64
Enterprise value/Revenue	2.89
Enterprise value/EBITDA	9.27

Income statement

Revenue (ttm)	45.7B
Revenue Per Share (ttm)	36.51
Quarterly Revenue Growth (yoy)	-3.30%
Gross Profit (ttm)	31.7B
EBITDA	13.33B
Net Income available to Common (ttm)	9.07B
Diluted EPS (ttm)	7.22
Quarterly Earnings Growth (yoy)	21.60%

Price history

Beta (5 year Monthly)	0.43
52-Week Change	4.30%
S&P500 52-Week Change	19.53%
52 Week High	105.18
52 Week Low	80.60
50-Day Moving Average	87.70
200-Day Moving Average	96.02

Profitability

Profit Margin	19.84%
Operating Margin (ttm)	27.38%

Fiscal Year

Fiscal year ends	Dec 31, 2022
Most Recent Quarter (mrq)	Sep 30, 2023

Management Effectiveness

Return on Assets (ttm)	N/A
Return on Equity (ttm)	N/A

Statistics

Avg Vol (3 month)	1.66M
Avg Vol (10 day)	1.1M
Shares Outstanding	1.25B
Implied Shares Outstanding	1.26B
Float 8	1.11B
% Held by Insiders	11.37%
% Held by Institutions	47.35%
Shares Short	N/A
Short Ratio	N/A
Short % of Float	N/A
Short % of Shares Outstanding	N/A
Shares Short (prior month)	N/A

Dividend & Splits

Forward Annual Dividend Rate	3.56
Forward Annual Dividend Yield	3.74%
Trailing Annual Dividend Rate	0.00
Trailing Annual Dividend Yield	0.00%
5 Year Average Dividend Yield	3.73
Payout Ratio	49.31%
Dividend Date	N/A
Ex-Dividend Date	May 30, 2023
Last Split Factor	N/A
Last Split Date	N/A

Balance sheet

Total Cash (mrq)	7.99B
Total Cash Per Share (mrq)	6.39
Total Debt (mrq)	21.03B
Total Debt/Equity (mrq)	28.82%
Current Ratio (mrq)	N/A
Book Value Per Share (mrq)	58.03

Cash Flow Statement

Operating Cash Flow (ttm)	N/A
Levered Free Cash Flow (ttm)	N/A

Income statement

	ttm	12/31/2022	12/31/2021	12/31/2020
Chiffre d’affaires	45,699,000	45,389,000	39,175,000	37,369,000
Cost of Goods Sold (COGS) incl. D&A	13,922,000	13,695,000	12,255,000	12,159,000
Gross Profit	31,777,000	31,694,000	26,920,000	25,210,000
_OPERATING_EXPENSE	20,972,000	19,813,000	17,773,000	17,320,000
_OPERATING_INCOME	10,805,000	11,881,000	9,147,000	7,890,000
_NET_NON_OPERATING_INCOME	-284,000	-231,000	-333,000	-335,000
Other Income Expense	828,000	-1,228,000	-1,016,000	6,223,000
Pretax Income	11,349,000	10,422,000	7,798,000	13,778,000
_TAX_PROVISION	2,203,000	2,006,000	1,558,000	1,807,000
Earnings from Equity Interest Net of Tax	16,000	68,000	39,000	359,000
Net Income_COMMON_STOCKHOLDERS	9,066,000	8,371,000	6,223,000	12,294,000
_DILUTEDNet Income_COM_STOCKHOLDERS	9,066,000	8,371,000	6,223,000	12,294,000
_BASIC_EPS
_DILUTED_EPS
_BASIC_AVG_SHARES	1,251,750	1,251,900	1,252,500	1,253,600
_DILUTED_AVG_SHARES	1,253,860	1,256,900	1,257,900	1,260,100
_TOTAL_OPERATING_INCOME	11,636,000	10,656,000	8,126,000	14,113,000
_TOTAL_EXPENSES	34,894,000	33,508,000	30,028,000	29,479,000
Net Income_CONTINUING_DISCONTINUED_OPERATION	9,066,000	8,371,000	6,223,000	12,294,000
_NORMALIZED_INCOME	8,100,549	9,362,638	7,022,701	7,005,317
_INTEREST_INCOME	584,000	241,000	54,000	103,000
Interest Expense	868,000	472,000	403,000	434,000
_NET_INTEREST_INCOME	-284,000	-231,000	-333,000	-335,000
_EBIT	12,217,000	10,894,000	8,201,000	14,212,000
_EBITDA	14,271,000	14,314,000	11,552,000	17,883,000
_RECONCILED_COST_OF_REVENUE	13,922,000	12,328,000	10,484,000	10,169,000
_RECONCILED_DEPRECIATION	2,054,000	3,420,000	3,351,000	3,671,000
Net Income_CONTINUING_OPERATION_NET_MINORITY_INTEREST	9,066,000	8,371,000	6,223,000	12,294,000
_TOTAL_UNUSUAL_ITEMS_EXCLUDING_GOODWILL	1,198,000	-1,228,000	-1,011,000	6,087,000
_TOTAL_UNUSUAL_ITEMS	1,198,000	-1,228,000	-1,011,000	6,087,000
_NORMALIZED_EBITDA	13,073,000	15,542,000	12,563,000	11,796,000
_TAX_RATE_CALCS	0	0	0	0
_TAX_EFECT_UNUSUAL_ITEMS	232,549	-236,362	-211,299	798,317

Balance sheet

Fiscal year is January-December. All values EUR Millions.

2022

2021

2020

2019

2018

_TXT_5_Y_TREND

Cash & Short Term Investments

12,736

10,098

13,915

9,742

6,925

Cash Only

12,736

10,098

13,915

9,742

6,925

Cash & Short Term Investments_GROWTH

26.12%

-27.43%

42.84%

40.68%

-

Cash & ST Investments / Total AssetsTotal Assets

10.05%

8.40%

12.16%

8.64%

6.22%

Total Accounts Receivable

10,746

9,787

9,953

10,083

9,345

Accounts Receivables, Net

8,424

7,568

7,491

7,937

7,260

Accounts Receivables, Gross

8,537

7,705

7,633

8,090

7,430

Bad Debt/Doubtful Accounts

(113)

(137)

(142)

(153)

(170)

Other Receivables

2,322

2,219

2,462

2,146

2,085

Accounts Receivables, Gross

9.80%

-1.67%

-1.29%

7.90%

-

Accounts Receivable Turnover

4.00

3.86

3.62

3.58

3.69

Inventories

8,960

8,715

8,352

7,994

7,477

Finished Goods

2,501

2,412

2,521

2,385

2,373

Work in Progress

4,985

5,025

4,856

4,522

4,088

Raw Materials

1,474

1,278

975

1,087

1,016

Other Current Assets

1,584

1,964

1,483

792

832

Prepaid Expenses

714

615

525

493

469

Miscellaneous Current Assets

870

1,349

958

299

363

Total Current Assets

34,026

30,564

33,703

28,611

24,579

Net Property, Plant & Equipment

11,684

11,976

10,563

11,017

9,651

Property, Plant & Equipment - Gross

25,739

26,758

24,367

24,868

22,697

Buildings

7,328

7,170

6,828

7,282

6,883

Land & Improvements

237

240

236

255

283

Machinery & Equipment

10,848

11,648

11,127

11,053

10,468

Construction in Progress

2,996

3,097

2,454

2,391

2,484

Other Property, Plant & Equipment

2,515

2,655

2,524

2,587

2,579

Accumulated Depreciation

14,055

14,782

13,804

13,851

13,046

Buildings

4,225

4,190

3,898

4,065

3,796

Land & Improvements

10

9

10

11

19

Machinery & Equipment

7,637

8,340

7,792

7,660

7,230

Construction in Progress

168

128

123

131

87

Other Property, Plant & Equipment

2,015

2,115

1,981

1,984

1,914

Total Investments and Advances

2,765

2,425

2,129

5,303

5,550

LT Investment - Affiliate Companies

677

250

201

3,591

3,402

Other Long-Term Investments

2,088

2,175

1,928

1,712

2,148

Long-Term Note Receivable

452

485

537

685

620

Intangible Assets

71,532

69,463

62,705

61,091

66,124

Net Goodwill

49,892

48,056

44,364

44,519

44,235

Net Other Intangibles

21,640

21,407

18,341

16,572

21,889

Other Assets

882

731

600

595

271

Deferred Charges

555

467

269

270

203

_TANGIBLEOther Assets

327

264

331

325

68

Total Assets

126,722

120,242

114,413

112,736

111,408

Assets - Total - Growth

5.39%

5.09%

1.49%

1.19%

-

Asset Turnover

0.35

-

Return On Average Assets

6.78%

-

All values EUR Millions.

2022

2021

2020

2019

2018

_TXT_5_Y_TREND

ST Debt & Current Portion LT Debt

4,451

3,452

2,999

4,815

2,633

Short Term Debt

4,174

3,183

2,767

4,554

2,629

Current Portion of Long Term Debt

277

269

232

261

4

Accounts Payable

6,813

6,180

5,295

5,313

5,041

Accounts Payable_GROWTH

10.24%

16.71%

-0.34%

5.40%

-

Income Tax Payable

574

737

951

613

733

Other Current Liabilities

12,126

10,926

10,003

9,640

8,969

Accrued Payroll

-

1,978

1,989

Miscellaneous Current Liabilities

12,126

10,926

10,003

7,662

6,980

Total Current Liabilities

23,964

21,295

19,248

20,381

17,376

Current Ratio

1.42

1.44

1.75

1.40

1.41

Quick Ratio

1.05

1.03

1.32

1.01

0.98

Cash Ratio

0.53

0.47

0.72

0.48

0.40

Long-Term Debt

16,761

18,962

20,676

21,118

22,007

Long-Term Debt_EXC_CAPILeases

14,857

17,123

19,745

20,131

21,989

Non-Convertible Debt

14,857

17,123

19,745

20,131

21,989

_CAPILeases_OBLIGATIONS

-

18

Provision for Risks & Charges

5,822

6,430

6,998

7,353

6,883

Deferred Taxes

(3,540

(2,981

(2,406

(3,140

(1,199

Deferred Taxes_CREDIT

1,841

1,617

1,770

2,294

3,414

Deferred Taxes_DEBIT

5,381

4,598

4,176

5,434

4,613

_OTHER_LIABILITIES

3,182

2,907

2,469

2,482

2,693

Other Liabilities (excl.)Deferred Income

3,182

2,907

2,469

2,482

2,693

Total Liabilities

51,570

51,211

51,161

53,628

52,373

Total LiabilitiesTotal Assets

40.70%

42.59%

44.72%

47.57%

47.01%

Common Equity (Total)

74,784

68,681

63,106

58,934

58,876

Common Stock Par/Carry Value

2,522

2,527

2,518

2,508

2,495

Additional Paid-In Capital/Capital Surplus

125

532

362

147

-

Retained Earnings

66,734

63,013

60,149

51,780

53,106

Cumulative Translation Adjustment/Unrealized For. Exch. Gain

1,451

(857

(3,356

632

(167

Other Appropriated Reserves

4,658

4,405

4,138

3,876

3,595

Treasury Stock

(706

(939

(705

(9

(153

_COMMON_EQUITYTotal Assets

59.01%

57.12%

55.16%

52.28%

52.85%

Total Shareholders' Equity

74,784

68,681

63,106

58,934

58,876

Total Shareholders' EquityTotal Assets

59.01%

57.12%

55.16%

52.28%

52.85%

Accumulated Minority Interest

368

350

146

174

159

Total Equity

75,152

69,031

63,252

59,108

59,035

Liabilities & Shareholders' Equity

126,722

120,242

114,413

112,736

111,408

Cash flow

	ttm	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Operating Cash Flow	10,258,000	10,258,000	10,526,000	10,522,000	7,418,000
Investing Cash Flow	-6,200,000	-6,200,000	-2,075,000	-7,298,000	3,619,000
Financing Cash Flow	-8,052,000	-8,052,000	-5,821,000	-7,056,000	-6,485,000
End cash position	8,710,000	8,710,000	12,736,000	10,098,000	13,915,000
Income Tax	2,623,000	2,623,000	2,452,000	1,280,000	2,051,000
Interest Paid Supplemental Data	559,000	559,000	380,000	334,000	315,000
Capital Expenditure	-3,024,000	-3,024,000	-2,201,000	-2,043,000	-2,083,000
Issuance of Capital Stock	195,000	195,000	188,000	186,000	203,000
Issuance of Debt	48,000	48,000	1,549,000	0	2,019,000
Repayment of Debt	-3,949,000	-3,949,000	-3,009,000	-2,390,000	-4,186,000
Repurchase of Capital Stock	-593,000	-593,000	-497,000	-382,000	-822,000
Free Cash Flow	7,234,000	7,234,000	8,325,000	8,479,000	5,335,000

Développement durable

Last update on 9/2023

Secteurs d'implication

Products and Activities	Significant Involvement
Alcoholic Beverages	No
Adult Entertainment	No
Gambling	No
Tobacco Products	No
Animal Testing	Yes
Fur and Specialty Leather	No
Controversial Weapons	No
Small Arms	No
Catholic Values	Yes
GMO	No
Military Contracting	No
Pesticides	No
Thermal Coal	No
Palm Oil	No

Scores ESG

Evaluation du risque : 21 34th percentile Medium

Risques sur l'Environnement

0

0.9

Négligeable

Faible

Moyen

Élevé

Sévère

20

Risques sur la Soutenabilité

0

13.7

Négligeable

Faible

Moyen

Élevé

Sévère

20

Risques sur la Gouvernance

0

6.9

Négligeable

Faible

Moyen

Élevé

Sévère

20

Niveau de controverse

0

4

Aucune

Faible

Modéré

Significatif

Grave

5

Analysts ratings

	3 months ago	1 month ago	Current
Buy	12	10	12
Overweight	2	3	3
Hold	6	7	6
Underweight	0	0	0
Sell	1	1	1
Consensus	Overweight	Overweight	Overweight

Earnings Per Shares

Quarterly

Actual Analyst range Consensus

2.50 2.00 1.50 1.00

Actual 0.93 0.92	Actual 1.19 1.10	Actual 0.96 0.92	Actual 1.35 1.37		1.73	1.87
Q42022	Q12023	Q2	Q3		Q4	Q12024

Annualy

13 10 8 5

Actual 6.66 4.41	8.21	8.02	9.25
FY 2022	FY 2023	FY 2024	FY 2025

SAN will report Q4 earnings on 04/25/2024

Q4 2023 Estimate Trends
Current:	^€1.73
1 month ago:	^€0.93
3 months ago:	^€0.92

Q1 2024 Estimate Trends
Current:	^€1.87
1 month ago:	^€0.99
3 months ago:	^€1.05

Competitors

Sanofi by Warren Buffet


Compte de résultat
Croissance du CA	>0%	0.00%	0.00%	0.00%	0.00%
Croissance des bénécices brut	>0%	0.00%	0.00%	0.00%	0.00%
Croissance du résultat d'exploitation avant intérêts et impôts (EBIT)	>0%	0.00%	0.00%	0.00%	0.00%
Croissance résultat net	>15%	0.00%	0.00%	0.00%	0.00%
Profitabilité pour l'actionnaire (ROE)		0.00%	0.00%	0.00%	0.00%	0.00%
Marge brut	>40%	0.00%	0.00%	0.00%	0.00%	0.00%
Marge opérationnelle		0.00%	0.00%	0.00%	0.00%	0.00%
Marge nette	>10%	0.00%	0.00%	0.00%	0.00%	0.00%
Capacité à attirer de nouveaux clients	<30%	0.00%	0.00%	0.00%	0.00%	0.00%
Coût de la R&D	<5%	0.00%	0.00%	0.00%	0.00%	0.00%
Charges d'intérêts	<15%	0.00%	0.00%	0.00%	0.00%	0.00%
Bilan
Liquidité : Capacité de l'entreprise à rembourser ses dettes à COURT terme
Ratio de liquidité général (current ratio)	>1	1.48	1.43	1.74	1.40	1.41
Ratio de liquidité restreinte (quick ratio)	>1	0.52	0.43	0.63	0.45	0.35
Ratio de liquidité immédiate (cash ratio)	>1	0.10	0.08	0.11	0.08	0.05
Solvabilité : Capacité de l'entreprise à rembourser ses dettes à LONG terme
Approche 1	<0	2 121	7 025	5 830	10 389	15 064
Net LT debt to equity	<100%	2.84%	10.23%	9.24%	17.63%	25.59%
Approche 2		-	-	-	-	-
Dette nette totale / capitaux propres	<100%	-	-	-	-	-
Approche 3		-	-	-	-
Net total debt to equity	<100%	-	-	-	-
Levier Financier
Passif total / cap. propres	<2	-	-	-	-
Rendement du capitaux propre	> 15%	-	-	-	-

Résultats du ratio de Piotroski F-Score Stock Screen pour Sanofi

Objet : Estimer la qualité fondamentale de vos placements (fondamentaux solides + valeur résiliente à long terme) par M. Joseph Piotroski
Objectif : Score entre 8 et 9

Thème	2021	2020	2019	2018	2017	Formule
Rentabilité
Rendement de l'actif (ROA)	0	0	0	0	0	(Résultat net / Actifs totaux) > 0
Flux de trésorerie d'exploitation	1	1	1	1	-	Flux de trésorerie > 0
Direction du ROA					-	Si ROA N > ROA N-1
Vérification de la compatbilité de l'exercice					-	Cashflow opérationnel > Résultat net
Structure du Capital
Ratio Dette LT / Actifs Totaux	0	0	0	0	-	Dette long terme / Actifs Totaux N sur N-1
Ratio de liquidité (Current ratio)	1	0	1	0	-	Actifs CT / Passifs CT N sur N-1
Emission d'actions	1	1	1	1	-	Emission d'actions (ou rachat d'action) oui/non
Efficacité opérationnelle
Orientation de la marge brute					-	Marge brute en hausse ? oui/non
Rotation des actifs					-	(Ventes / actifs) > 0
	2	2	2	2	-

FY 2023 Estimate Trends
Current:	^€8.21
1 month ago:	^€4.37
3 months ago:	^€4.40

FY 2024 Estimate Trends
Current:	^€8.02
1 month ago:	^€4.30
3 months ago:	^€4.73

Sanofi - SAN

Finances Sanofi

Earnings & revenue

Total revenue

Net Income

Gross profit

Free Cash Flow

Valuation

Financials

Statistics

Valuation

Income statement

Price history

Profitability

Fiscal Year

Management Effectiveness

Statistics

Dividend & Splits

Balance sheet

Cash Flow Statement

Income statement

Balance sheet

Cash flow

Développement durable

Secteurs d'implication

Scores ESG

Niveau de controverse

Analysts ratings

Analysts ratings

Earnings Per Shares

Competitors

Sanofi by Warren Buffet

Résultats du ratio de Piotroski F-Score Stock Screen pour Sanofi